Thetford Mines, Quebec – February 18, 2019 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is pleased to announce that the transaction with Strides Pharma Canada inc. (“Strides”) previously announced in its press releases dated December 4, 2018 and February 1st, 2019, according to which Strides acquired 80% of the issued and outstanding shares of its subsidiary Pharmapar Inc. (“Pharmapar”) has been completed.
- LETTER FROM THE PRESIDENT
- KDA Group selected for 2020 TSX venture top 50 list
- kDa Group develops a technological platform for its subsidiary AlliancePharma
- kDa Group develops a cannabis-based medical products eduction program for pharmacists and technicians
- Expansion of the CanNorth Medic plant for cannabis-based medical products